Sign In
Buy RYN
$21.78
+0.390 (+1.82%)
At Close: Jul 31, 2026
Here's Why Rayonier (RYN) is an Apt Portfolio Pick for Now
03:06pm, Friday, 22'nd Mar 2024
A solid timberland portfolio and developments in biogenetics and cloning are likely to aid Rayonier (RYN).
Rayonier: Favorable Takeaways From Latest Investor Events
05:45am, Friday, 08'th Mar 2024
RYN's land-based solutions and real estate development businesses are expected to be the key growth drivers for the company in the medium to long term. Rayonier's $1 billion asset disposal target will
Rayonier to Host 2024 Investor Day in New York City Today at 9:00 AM ET
07:30am, Wednesday, 28'th Feb 2024
WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE: RYN), a leading timberland REIT, will host an Investor Day in New York City today starting at 9:00 AM ET as previously announced. Presentations w
Rayonier Announces Additional Pore Space Lease Agreements with ExxonMobil
04:15pm, Wednesday, 21'st Feb 2024
WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier (NYSE:RYN) today announced that it has entered into additional underground pore space lease agreements with ExxonMobil covering approximately 33,000 acres of
Rayonier to Present at Upcoming Investor Conferences
04:15pm, Tuesday, 20'th Feb 2024
WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier (NYSE:RYN) announced today that Mark McHugh, President and Chief Financial Officer, will present at the Raymond James 45th Annual Institutional Investors Con
Rayonier Announces First Quarter 2024 Dividend
09:15am, Thursday, 15'th Feb 2024
WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) announced today that the Company's board of directors has declared a first quarter cash dividend of $0.285 per common share. The dividend is
Rayonier (RYN) Q4 Earnings Meet Estimates, Revenues Lag
11:41am, Thursday, 01'st Feb 2024
Rayonier's (RYN) Q4 earnings meet estimates despite lower-than-anticipated revenues. The pro forma operating income declines in most segments excluding Real Estate.
Rayonier (RYN) Reports Q4 Earnings: What Key Metrics Have to Say
07:36pm, Wednesday, 31'st Jan 2024
The headline numbers for Rayonier (RYN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estim
Rayonier Reports Fourth Quarter 2023 Results
04:12pm, Wednesday, 31'st Jan 2024
WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) today reported fourth quarter net income attributable to Rayonier of $126.9 million, or $0.85 per share, on revenues of $467.4 million. This
Rayonier (RYN) Reports Next Week: Wall Street Expects Earnings Growth
11:07am, Wednesday, 24'th Jan 2024
Rayonier (RYN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Rayonier Scheduled to Release Fourth Quarter Earnings on January 31
04:15pm, Wednesday, 10'th Jan 2024
WILDLIGHT, Fla.--(BUSINESS WIRE)--Rayonier Inc. (NYSE:RYN) plans to release its fourth quarter 2023 earnings after the market closes on Wednesday, January 31, 2024. Rayonier will host a conference cal
Disinflation: A Gift That Keeps Giving
09:00am, Sunday, 24'th Dec 2023
U.S. equity markets extended their winning streak to an eighth week - the longest in five years - after inflation data both domestically and abroad showed a further cooling of price pressures. Extendi
Rayonier (RYN) Completes the Oregon Timberland Divestiture
12:02pm, Tuesday, 19'th Dec 2023
Rayonier (RYN) strategically divests Oregon timberland, aligning with its capital plans for enhanced shareholder value and long-term financial resilience.
Rayonier: Positive On Recent Corporate Actions (Rating Upgrade)
07:39pm, Tuesday, 12'th Dec 2023
Rayonier has put in place in a new 18-month $1 billion asset divestment plan, which will free up more excess capital for deleveraging, dividends, and buybacks. The current CFO, Mark McHugh, will be ap
Is it Wise for Investors to Retain Rayonier (RYN) Stock Now?
12:02pm, Friday, 24'th Nov 2023
While a solid timberland portfolio, developments in biogenetics and cloning, and capital realignment moves are likely to aid Rayonier (RYN), weak export market demand and high interest rates are woes.
